{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"23","upperLimit":"57","value":"40"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"30"}],"units":"Participants"}],"description":"Kaplan-Meier estimate of an event of death estimated at five years post-transplant. 95% confidence intervals were calculated from the logit transform of the Greenwood variance. The transformation was necessary to keep the estimate within the probability space of 0 to 100%.","dispersionType":"95% Confidence Interval","groups":[{"description":"IV Busulfan + 12 cGy FTBI + VP16 prior to allogeneic Bone Marrow Transplant\n\nbusulfan\n\ncyclosporine\n\netoposide\n\nmycophenolate mofetil\n\nallogeneic bone marrow transplantation\n\nallogeneic hematopoietic stem cell transplantation\n\nperipheral blood stem cell transplantation\n\ntotal-body irradiation","id":"OG000","title":"Busulfan, FTBI and VP16"}],"paramType":"NUMBER","populationDescription":"The Full Study Population","reportingStatus":"POSTED","timeFrame":"Date of Transplant to Five Years post-Transplant","title":"Overall Survival at 5 Years Post-Transplant.","type":"PRIMARY","unitOfMeasure":"percentage of survival probability"}